| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3436556 | American Journal of Obstetrics and Gynecology | 2009 | 5 Pages |
Abstract
A panel of 4 serum biomarkers effectively detected early-stage ovarian cancers with the highest reported overall sensitivity of 96%. Endometrioid tumors were detected at early stages with a sensitivity of 98%. Prospective clinical analysis of the panel is needed to validate it as an effective screening tool for early-stage ovarian cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Vladimir MD, Feng MD, Malaika MD, Michael MD, PhD, Terry PhD, Jenny MS, Srinivasa PhD, Robin MD, PhD,